Matrilysin inhibits proliferation and modulates sensitivity of lung cancer cells to FasL-mediated apoptosis

Medical Oncology

Volumn 25, Issue 4, 2008, Pages 419-430

  Liu, Hui ^a   Huang, Jing ^a   Wu, Benquan ^a   Zhou, Yuqi ^a   Zhu, Jiaxin ^a   Zhang, Tiantuo ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Lung cancer; Matrilysin; Matrix metalloproteinase; Proliferation

Indexed keywords

CELL SURFACE PROTEIN; FAS LIGAND; MATRILYSIN;

APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL GROWTH; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG ADENOCARCINOMA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; TUMOR CELL;

ADENOCARCINOMA; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FAS LIGAND PROTEIN; FLOW CYTOMETRY; HUMANS; LUNG NEOPLASMS; MATRIX METALLOPROTEINASE 7; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 58549094526     PISSN: 13570560     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12032-008-9057-z     Document Type: Article

References (26)

1. AR Nelson B Fingleton ML Rothenberg LM Matrisian 2000 Matrix metalloproteinases: biologic activity and clinical implications J Clin Oncol 18 1135 49
2. CL Wilson AJ Ouellette DP Satchell T Ayabe YS Lopez-Boado 1999 Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defense Science 286 113 7
3. W Ben L Claude W Carole 2004 Matrilysin (matrix metalloproteinase-7): a new promising drug target in cancer and inflammation? Cytokine Growth Factor Rev 15 111 5
4. I Masanori Y Hiroyuki A Yasushi M Yumiko S Yasuhisa 2006 Role of matrix metalloproteinase-7 (matrilysin) in human cancer invasion, apoptosis, growth, and angiogenesis Exp Biol Med 231 20 7
5. M Egeblad Z Werb 2002 New functions for the matrix metalloproteinases in cancer progression Nat Rev Cancer 2 161 74
6. LA Rudolph-Owen R Chan WJ Muller LM Matrisian 1998 The matrix metalloproteinase matrilysin influences early-stage mammary tumorigenesis Cancer Res 58 5500 6
7. N Mitsiades WH Yu V Poulaki M Tsokos I Stamenkovic 2001 Matrix metalloproteinase-7-mediated cleavage of Fas ligand protects tumor cells from chemotherapeutic drug cytotoxicity Cancer Res 61 577 81
8. S Strand P Vollmer L van den Abeelen D Gottfried V Alla 2004 Cleavage of CD95 by matrix metalloproteinase-7 induces apoptosis resistance in tumour cells Oncogene 23 3732 6
9. W-S Wang P-M Chen H-S Wang W-Y Liang Y Su 2006 Matrix metalloproteinase-7 increases resistance to Fas-mediated apoptosis and is a poor prognostic factor of patients with colorectal carcinoma Carcinogenesis 27 1113 20
10. T Vargo-Gogola B Fingleton HC Crawford LM Matrisian 2002 Matrilysin (matrix metalloproteinase-7) selects for apoptosis-resistant mammary cells in vivo Cancer Res 62 5559 63
11. WC Powell B Fingleton CL Wilson M Boothby LM Matrisian 1999 The metalloproteinase matrilysin proteolytically generates active soluble Fas ligand and potentiates epithelial cell apoptosis Curr Biol 9 1441 7
12. H Nailin I Yasushi K Masako I Takashi H Yohei 2002 MMP-7 (matrilysin) accelerated growth of human umbilical vein endothelial cells Cancer Lett 177 95 100
13. BC Patterson QA Sang 1997 Angiostatin-converting enzyme activities of human matrilysin (MMP-7) and gelatinase B/type IV collagenase (MMP-9) J Biol Chem 272 28823 5
14. D Liu J Nakano S Ishikawa H Yokomise M Ueno 2007 Overexpression of matrix metalloproteinase-7 (MMP-7) correlates with tumor proliferation, and a poor prognosis in non-small cell lung cancer Lung Cancer 58 384 91
15. J Safranek L Holubec Jr O Topolcan M Pesta J Klecka 2007 Expression of mRNA MMP-7 and mRNA TIMP-1 in non-small cell lung cancer Anticancer Res 27 2953 356
16. KJ Livak TD Schmittgen 2001 Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method Methods 25 402 408
17. XP Liu A Oga Y Suehiro T Furuya S Kawauchi 2002 Inverse relationship between matrilysin expression and proliferative activity of cells in advanced gastric carcinoma Hum Pathol 33 741 7
18. WG Jiang G Davies TA Martin C Parr G Watkins 2005 Targeting matrilysin and its impact on tumor growth in vivo: the potential implications in breast cancer therapy Clin Cancer Res 11 6012 9
19. Y Adachi H Yamamoto F Itoh Y Arimura M Nishi 2001 Clinicopathologic and prognostic significance of matrilysin expression at the invasive front in human colorectal cancers Int J Cancer 95 290 4
20. X Tan H Egami S Ishikawa H Sugita H Kamohara 2005 Involvement of matrix metalloproteinase-7 in invasion-metastasis through induction of cell dissociation in pancreatic cancer Int J Oncol 26 1283 9
21. CH Permila JM Lisa F Barbara MJ Oliver MM Lynn 2005 Proliferative effects of apical, but not basal, matrix metalloproteinase-7 activity in polarized MDCK cells Exp Cell Res 303 308 20
22. H Uramoto T Osaki M Inoue S Taga M Takenoyama 1999 Fas expression in non-small cell lung cancer: its prognostic effect in completely resected stage III patients Eur J Cancer 35 1462 5
23. M Nakamura G Matute-Bello W Conrad Liles S Hayashi O Kajikawa 2004 Differential response of human lung epithelial cells to Fas-induced apoptosis Am J Pathol 164 1949 58
24. AN Gloria B Thomas PF Sandra CL Jacob TS Christopher 1997 Human lung carcinomas express Fas ligand Cancer Res 57 1007 12
25. LM Coussens B Fingleton LM Matrisian 2002 Matrix metalloproteinase inhibitors and cancer: trials and tribulations Science 295 2387 92
26. JG Kendra W Zena K Farrah 2007 Matrix metalloproteinases in lung: multiple, multifarious, and multifaceted Physiol Rev 87 69 98